What is the price target for MCS stock?
9 analysts have analysed MCS and the average price target is 23.87 USD. This implies a price increase of 24.7% is expected in the next year compared to the current price of 19.14.
NYSE:MCS • US5663301068
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for MARCUS CORPORATION (MCS).
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2026-03-02 | Barrington Research | Maintains | Outperform -> Outperform |
| 2026-01-26 | Barrington Research | Maintains | Outperform -> Outperform |
| 2025-12-12 | Barrington Research | Maintains | Outperform -> Outperform |
| 2025-11-03 | Barrington Research | Maintains | Outperform -> Outperform |
| 2025-10-31 | Barrington Research | Maintains | Outperform -> Outperform |
| 2025-10-06 | Benchmark | Maintains | Buy -> Buy |
| 2025-09-23 | Barrington Research | Maintains | Outperform -> Outperform |
| 2025-08-04 | Barrington Research | Reiterate | Outperform -> Outperform |
| 2025-07-18 | Wedbush | Initiate | Outperform |
| 2025-05-23 | Barrington Research | Maintains | Outperform -> Outperform |
| 2025-05-06 | Barrington Research | Maintains | Outperform -> Outperform |
| 2025-04-15 | Barrington Research | Maintains | Outperform -> Outperform |
| 2025-04-11 | Benchmark | Reiterate | Buy -> Buy |
| 2025-03-03 | Barrington Research | Maintains | Outperform -> Outperform |
| 2025-02-27 | Barrington Research | Maintains | Outperform -> Outperform |
| 2025-01-30 | Benchmark | Reiterate | Buy -> Buy |
| 2024-11-25 | Benchmark | Maintains | Buy -> Buy |
| 2024-11-13 | Barrington Research | Maintains | Outperform -> Outperform |
| 2024-11-04 | Barrington Research | Maintains | Outperform -> Outperform |
| 2024-11-01 | Benchmark | Maintains | Buy -> Buy |
| 2024-10-31 | Barrington Research | Maintains | Outperform -> Outperform |
| 2024-10-02 | Benchmark | Maintains | Buy -> Buy |
| 2024-09-20 | Barrington Research | Maintains | Outperform -> Outperform |
| 2024-08-02 | Barrington Research | Maintains | Outperform -> Outperform |
| 2024-07-29 | Benchmark | Reiterate | Buy -> Buy |
| 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | ||
|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 729.575M 7.70% | 735.56M 0.82% | 758.458M 3.11% | 804.23M 6.03% | 829.53M 3.15% | 835.57M 0.73% | |
| EBITDA YoY % growth | 102.288M 32.84% | 90.951M -11.08% | 91.874M 1.01% | 113.86M 23.93% | 125.08M 9.85% | 835.57M 568.03% | |
| EBIT YoY % growth | 34.987M 253.40% | 22.993M -34.28% | 21.683M -5.70% | 34.859M 60.77% | 43.239M 24.04% | 50.197M 16.09% | |
| Operating Margin | 4.80% | 3.13% | 2.86% | 4.33% | 5.21% | 6.01% | |
| EPS YoY % growth | 0.30 168.18% | -0.26 -186.67% | 0.40 253.85% | 0.57 41.40% | 0.78 38.09% | 0.91 16.38% |
All data in USD
| Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | Q1 / 28 | Q2 / 28 | Q3 / 28 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.52 4.61% | 0.30 28.81% | 0.59 12.65% | 0.20 4.55% | -0.50 2.94% | 0.40 34.66% | 0.68 15.52% | 0.29 47.46% | -0.51 -1.21% | 0.50 24.81% | 0.60 -11.04% |
| Revenue Q2Q % growth | 150.78M 1.35% | 214.34M 4.03% | 230.14M 9.51% | 208.74M 7.88% | 155.07M 2.85% | 221.5M 3.34% | 238.13M 3.47% | 214.95M 2.97% | 165.7M 6.85% | 245.63M 10.89% | 233.08M -2.12% |
| EBITDA Q2Q % growth | 878.7K 122.31% | 34.742M -28.56% | 47.126M -37.11% | 31.085M -60.05% | 2.719M 209.43% | 39.254M 12.99% | 49.701M 5.46% | 34.593M 11.29% | N/A | N/A | N/A |
| EBIT Q2Q % growth | -19.202M 11.82% | 15.384M 16.65% | 27.805M 22.71% | 10.873M 42.82% | -18.242M 5.00% | 19.482M 26.64% | 31.156M 12.05% | 14.962M 37.61% | N/A | N/A | N/A |
All data in USD
9 analysts have analysed MCS and the average price target is 23.87 USD. This implies a price increase of 24.7% is expected in the next year compared to the current price of 19.14.
MARCUS CORPORATION (MCS) will report earnings on 2026-04-30.
The consensus EPS estimate for the next earnings of MARCUS CORPORATION (MCS) is -0.52 USD and the consensus revenue estimate is 150.78M USD.
The number of analysts covering MARCUS CORPORATION (MCS) is 9.